← Back to Vaccine Database

MF59-ATIV

Live attenuated vaccine · VDDBV0480

Target & Classification

InfluenzaInfluenza virus
Live attenuated vaccine
Influenza
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT02529904 Phase 2Influenza